359 related articles for article (PubMed ID: 29217140)
1. Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12.
Akcora BÖ; Storm G; Bansal R
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):804-818. PubMed ID: 29217140
[TBL] [Abstract][Full Text] [Related]
2. The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice.
Okazaki H; Sato S; Koyama K; Morizumi S; Abe S; Azuma M; Chen Y; Goto H; Aono Y; Ogawa H; Kagawa K; Nishimura H; Kawano H; Toyoda Y; Uehara H; Kouji H; Nishioka Y
Exp Lung Res; 2019 Sep; 45(7):188-199. PubMed ID: 31298961
[No Abstract] [Full Text] [Related]
3. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM
Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice.
Osawa Y; Oboki K; Imamura J; Kojika E; Hayashi Y; Hishima T; Saibara T; Shibasaki F; Kohara M; Kimura K
EBioMedicine; 2015 Nov; 2(11):1751-8. PubMed ID: 26870800
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl
Öztürk Akcora B; Storm G; Prakash J; Bansal R
Sci Rep; 2017 Mar; 7():44545. PubMed ID: 28291245
[TBL] [Abstract][Full Text] [Related]
6. TG101348, a selective JAK2 antagonist, ameliorates hepatic fibrogenesis
Akcora BÖ; Dathathri E; Ortiz-Perez A; Gabriël AV; Storm G; Prakash J; Bansal R
FASEB J; 2019 Aug; 33(8):9466-9475. PubMed ID: 31100032
[TBL] [Abstract][Full Text] [Related]
7. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the canonical Wnt signaling pathway by a β-catenin/CBP inhibitor prevents heart failure by ameliorating cardiac hypertrophy and fibrosis.
Methatham T; Tomida S; Kimura N; Imai Y; Aizawa K
Sci Rep; 2021 Jul; 11(1):14886. PubMed ID: 34290289
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
Tang Y; Berlind J; Mavila N
Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
[TBL] [Abstract][Full Text] [Related]
10. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model.
Tokunaga Y; Osawa Y; Ohtsuki T; Hayashi Y; Yamaji K; Yamane D; Hara M; Munekata K; Tsukiyama-Kohara K; Hishima T; Kojima S; Kimura K; Kohara M
Sci Rep; 2017 Mar; 7(1):325. PubMed ID: 28336942
[TBL] [Abstract][Full Text] [Related]
12. LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p.
Yu F; Guo Y; Chen B; Shi L; Dong P; Zhou M; Zheng J
Cell Physiol Biochem; 2017; 41(5):1970-1980. PubMed ID: 28391277
[TBL] [Abstract][Full Text] [Related]
13. Canonical Wnt pathway inhibitor ICG-001 induces cytotoxicity of multiple myeloma cells in Wnt-independent manner.
Grigson ER; Ozerova M; Pisklakova A; Liu H; Sullivan DM; Nefedova Y
PLoS One; 2015; 10(1):e0117693. PubMed ID: 25635944
[TBL] [Abstract][Full Text] [Related]
14. DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl
Liu QQ; Chen J; Ma T; Huang W; Lu CH
Sci Rep; 2024 Apr; 14(1):9425. PubMed ID: 38658618
[TBL] [Abstract][Full Text] [Related]
15. Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis.
Hao S; He W; Li Y; Ding H; Hou Y; Nie J; Hou FF; Kahn M; Liu Y
J Am Soc Nephrol; 2011 Sep; 22(9):1642-53. PubMed ID: 21816937
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
[TBL] [Abstract][Full Text] [Related]
17. CD73 regulates hepatic stellate cells activation and proliferation through Wnt/β-catenin signaling pathway.
Jia WQ; Zhou TC; Dai JW; Liu ZN; Zhang YF; Zang DD; Lv XW
Eur J Pharmacol; 2021 Jan; 890():173667. PubMed ID: 33121948
[TBL] [Abstract][Full Text] [Related]
18. The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis.
Bansal R; van Baarlen J; Storm G; Prakash J
Sci Rep; 2015 Dec; 5():18272. PubMed ID: 26658360
[TBL] [Abstract][Full Text] [Related]
19. Pinostilbene hydrate suppresses hepatic stellate cell activation via inhibition of miR-17-5p-mediated Wnt/β-catenin pathway.
Zhou G; Li C; Zhan Y; Zhang R; Lv B; Geng W; Zheng J
Phytomedicine; 2020 Dec; 79():153321. PubMed ID: 32919323
[TBL] [Abstract][Full Text] [Related]
20. Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1.
Zhang C; Liu XQ; Sun HN; Meng XM; Bao YW; Zhang HP; Pan FM; Zhang C
Int Immunopharmacol; 2018 Oct; 63():183-190. PubMed ID: 30098497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
